Physician profile
Morris Barnard
NPI 1285852095
$2,820.75
in general payments reported to CMS, 2019-2025
17 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $944 · 2020: $698 · 2021: $206 · 2022: $590 · 2023: $258 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $383.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $538.79 | 2019-2022 | |
| Abbott Laboratories | $311.58 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $246.14 | 2020 | |
| Intuity Medical INC | $234.23 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Janssen Pharmaceuticals, INC | $229.16 | 2019-2020 | |
| Gilead Sciences, INC. | $159.78 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $153.71 | 2019 | |
| Althera Pharmaceuticals LLC | $153.00 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $135.00 | 2023 | Austedo |
| Ascendis Pharma Endocrinology INC | $125.00 | 2025 | Yorvipath |
| Boston Scientific Corporation | $125.00 | 2019 | |
| Horizon Therapeutics Plc | $124.99 | 2019 | |
| Vifor Pharma, INC. | $121.95 | 2019 | |
| Abbvie INC. | $54.16 | 2020 | |
| Redhill Biopharma INC. | $48.39 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $35.87 | 2019-2020 | |
| Amgen INC. | $24.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morris Barnard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.